Evidence map›Paper›PMID 26392462›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Stat1 Regulates Lupus-like Chronic Graft-versus-Host Disease Severity via Interactions with Stat3.

Wen-Hai Shao, Ana M Gamero, Yuxuan Zhen, Monica J Lobue, Stephen O Priest, Hazem J Albandar, Philip L Cohen

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. An aberrant STAT pathway is central to COVID-19.Cell death and differentiation · 2020
    Review
  8. Article
  9. Article
  10. T-betArthritis research & therapy · 2017
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Wen-Hai ShaoSection of Rheumatology, Department of Medicine, Temple University, Philadelphia, PA 19140; and wshao@temple.edu.
Ana M GameroDepartment of Medical Genetics and Molecular Biochemistry, Temple University, Philadelphia, PA 19140.
Yuxuan ZhenSection of Rheumatology, Department of Medicine, Temple University, Philadelphia, PA 19140; and.
Monica J LobueSection of Rheumatology, Department of Medicine, Temple University, Philadelphia, PA 19140; and.
Stephen O PriestSection of Rheumatology, Department of Medicine, Temple University, Philadelphia, PA 19140; and.
Hazem J AlbandarSection of Rheumatology, Department of Medicine, Temple University, Philadelphia, PA 19140; and.
Philip L CohenSection of Rheumatology, Department of Medicine, Temple University, Philadelphia, PA 19140; and.
Temple University · US

Funding

A critical role of TAM receptors in autoimmune nephritisK01DK095067 · NIDDK · UNIVERSITY OF CINCINNATI · PI SHAO, WEN-HAI · 2013 to 2017
$647k
Aggregated MAVS and Type I Interferon Production in SLER21AR065692 · NIAMS · TEMPLE UNIV OF THE COMMONWEALTH · PI COHEN, PHILIP L · 2014 to 2015
$378k
NIAMS NIH HHS R21 AR065692NIAMS NIH HHS R21AR065692NIDDK NIH HHS DK095067NIDDK NIH HHS K01 DK095067
6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) is a complex multisystem autoimmune disease, characterized by a spectrum of autoantibodies that target multiple cellular components. Glomerulonephritis is a major cause of morbidity in patients with SLE. Little is known about the pathogenesis of SLE renal damage and compromised renal function. Activation of both Stat1 and Stat3 has been reported in lupus and lupus nephritis. The reciprocal activation of these two transcription factors may have a major impact on renal inflammation. To study the role of Stat1 in a lupus model, we induced lupus-like chronic graft-versus-host disease (cGVHD) in Stat1-knockout (KO) and wild-type (WT) mice by i.p. injection of class II-disparate bm12 splenocytes. WT recipients of these alloreactive cells developed anti-dsDNA autoantibodies starting at week 2 as expected, with a decline after week 4. In contrast, Stat1-KO hosts exhibited a prolonged and significant increase of anti-dsDNA autoantibody responses compared with WT mice (week 4 to week 8). Increased autoantibody titers were accompanied by increased proteinuria and mortality in the cGVHD host mice lacking Stat1. Further analysis revealed expression and activation of Stat3 in the glomeruli of Stat1-KO host mice but not WT mice with cGVHD. Glomerular Stat3 activity in the Stat1-KO mice was associated with increased IL-6 and IFN-γ secretion and macrophage infiltration. Interactions between Stat1 and Stat3 thus appear to be crucial in determining the severity of lupus-like disease in the cGVHD model.

Indexed as

AnimalsAutoantibodiesB-LymphocytesChronic DiseaseGraft vs Host DiseaseInterferon-gammaInterleukin-6Lupus NephritisLymphocyte ActivationMiceMice, Inbred C57BLSTAT1 Transcription FactorSTAT3 Transcription FactorAutoantibodiesInterferon-gammaInterleukin-6Stat1 protein, mouseSTAT1 Transcription FactorStat3 protein, mouseSTAT3 Transcription Factor

Identifiers

PMID26392462
PMCPMC4610853
OpenAlexW2282036468

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.